Select language:

Scientists: Sputnik V is twice as good at resisting omicron as Pfizer

 / Главная / Russkiy Mir Foundation / News / Scientists: Sputnik V is twice as good at resisting omicron as Pfizer

Scientists: Sputnik V is twice as good at resisting omicron as Pfizer


20.01.2022

Photo credit: Y. Ivanko / mos.ru (CC BY 4.0)

Antibody titers to the omicron strain is more than two times higher after applying Sputnik V compared to two injections of the Pfizer vaccine, RIA Novosti reports. This conclusion was made by a joint study of the Gamaleya Center and the Lazzaro Spallanzani National Institute for Infectious Diseases.

The Russian Direct Investment Fund notes that the antibody titer after Sputnik V is 2.1 times higher in general and 2.6 times higher three months after vaccination.

The study was conducted under equal laboratory conditions at the Spallanzani Institute in Italy, based on comparable serum samples from individuals vaccinated with Sputnik V and Pfizer with similar levels of IgG antibodies and virus-neutralizing activity to the original strain registered in Wuhan.

Sputnik V demonstrated very high efficiency during its use in San Marino. These conclusions were made by scientists from the Spallanzani Institute. According to the scientists, the effectiveness of Sputnik V at almost 100%, no serious side effects were recorded.

Russkiy Mir

News by subject

Publications

Marco Maggi: ”Russian to the Bone" 20.01.2024
Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.